Security record · archived quarter
NVS
Novartis AG · Healthcare · Drug Manufacturers - General
13Tracked holders
—Δ holders
33.92MShares held
$3.61BReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 125 | +1 | 102.39M | $16.04B | +8 | −7 |
| Q1 2026 | 126 | +1 | 113.27M | $17.29B | +8 | −7 |
| Q4 2025 | 124 | +1 | 102.45M | $14.13B | +1 | — |
| Q3 2025 | 20 | -1 | 49.48M | $6.35B | — | −1 |
| Q2 2025 | 18 | 0 | 41.97M | $5.08B | +2 | −2 |
| Q1 2025 | 16 | +1 | 41.02M | $4.58B | +1 | — |
| Q4 2024 | 15 | +1 | 35.01M | $3.41B | +1 | — |
| Q3 2024 | 13 | 0 | 33.66M | $3.89B | — | — |
| Q2 2024 | 13 | — | 33.92M | $3.61B | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 12.24M | — | $1.30B | 0.8% | n/c | 1 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 12.18M | — | $1.30B | 0.9% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.38M | — | $466.79M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.38M | — | $466.79M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.38M | — | $466.79M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.38M | — | $466.79M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.38M | — | $466.79M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.38M | — | $466.79M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.38M | — | $466.79M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 4.38M | — | $466.79M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 2.50M | — | $266.13M | 0.5% | n/c | 1 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 1.47M | — | $156.94M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 630.71K | — | $67.14M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 246.56K | — | $26.25M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 156.41K | — | $16.65M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Tweedy, Browne ✦ | 87.61K | — | $9.33M | 0.4% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 9.70K | — | $1.03M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 9.70K | — | $1.03M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 8.86K | — | $943,555 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 7.09K | — | $755,000 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 7.09K | — | $755,000 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 2.84K | — | $301,921 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 1.31M shares, $431.09M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API